Tekedia Capital Invests in Unsupervised Biological AI Company Exonic - Tekedia

Tekedia Capital has invested in Exonic, a startup building unsupervised biological AI foundation models.

Exonic focuses on making sense of heterogeneous, unstructured biological data, including large noisy datasets.

The company says broader data learning can help speed progress in synthetic biology, cell targeting, and biological manufacturing.

The investment reflects rising interest in AI tools that can unlock breakthroughs across life sciences.